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ETATE-OF-THE-ART PAPER2789Bicuspid Aortic Valve Diseaseamuel C. Siu, Candice K. Silversides
icuspid aortic valve (BAV) disease is the most common congenital cardiac defect. While BAV
ay be found in isolation, it is often associated with other congenital cardiac lesions, particularly
ilation of the proximal ascending aorta. Changes in the aortic media may be present independent
f valvular dysfunction. Since BAV is a disease of both the valve and the aorta, surgical decision-
aking is more complicated. This paper by Siu and Silversides reviews the genetics, pathobiology,
nd clinical course of BAV, including the recommended intervals for surveillance of the valve and
he ascending aorta. Future lines of inquiry into the disease are outlined.VIEWPOINT IEWPOINT2801Medical Professional Liability and Health Care System Reformames T. Dove, John E. Brush Jr, Richard A. Chazal, William J. Oetgen
ew issues elicit more emotion from physicians than medical malpractice, with its
onnotations of guilt and the potential impact to career and finances. Despite the widespread
mpact on the practice of medicine, useful statistics are difficult to come by, including the
umbers of cases, judgments, and settlements. Defensive medicine may add 5% to 9% to the
ost of medical care. In this Viewpoint paper, Dove and colleagues review several potential
emedies including the use of special courts for these complaints, requirements for
ertification of merit, and the addition of evidence-based criteria rather than the more
ebulous community standard of care.CLINICAL RESEARCH LINICAL TRIAL2804Warfarin Genotyping Reduces Hospitalization Ratesobert S. Epstein, Thomas P. Moyer, Ronald E. Aubert, Dennis J. O’Kane, Fang Xia,
obert R. Verbrugge, Brian F. Gage, J. Russell Teagarden
enotypic variations in CYP2C9 and VKORC1 can affect warfarin dosing. This study by
pstein and colleagues was designed to determine whether genotype testing for patients
nitiating warfarin treatment would reduce the incidence of complications. A genetic test was
ailed to patients with a new prescription for warfarin; the results were sent to the ordering
hysician with advice suggesting which patients might require doses higher or lower than
verage. Compared to the historical control group, the genotyped cohort had 31% fewer
ospitalizations overall and 28% fewer hospitalizations for bleeding or thromboembolism.
arfarin genotyping may improve safety and efficacy when initiating warfarin.ditorial Comment: Geoffrey S. Ginsburg, Deepak Voora, p. 2813
(continued on page A-18)
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EORONARY ARTERY DISEASE2816Angiographic Versus Functional Severity of Coronary Artery Stenosesim A. L. Tonino, William F. Fearon, Bernard De Bruyne, Keith G. Oldroyd, Massoud A. Leesar,
eter N. Ver Lee, Philip A. MacCarthy, Marcel van’t Veer, Nico H. J. Pijls
n the FAME (Fractional Flow Reserve Versus Angiography in Multivessel Evaluation)
tudy, fractional flow reserve (FFR)-guided therapy reduced major adverse cardiac events
ompared with angiography alone for guiding percutaneous coronary intervention. This paper
y Tonino and colleagues analyzed the frequency of FFR functional lesions, defined as an
FR 0.80, for angiographic stenoses of varying severity. For lesions deemed to be 50% to
0% stenotic by angiography, only 35% were functionally significant. For 71% to 90%
ngiographic stenoses, 80% were functionally significant and 20% were not. In patients with
ngiographically-defined multivessel disease, only 46% had functional multivessel disease
2 coronary arteries with FFR 0.80). Measuring FFR can significantly alter the need for
evascularization.ditorial Comment: Robert J. Applegate, p. 2822ORONARY ARTERY DISEASE2825Impaired CFR Predicts Increased Risk in Women40
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p=0.003 (Log Rank)arl J. Pepine, R. David Anderson, Barry L. Sharaf, Steven E. Reis, Karen M. Smith,
ileen M. Handberg, B. Delia Johnson, George Sopko, C. Noel Bairey Merz
epine and colleagues investigated whether coronary microvascular dysfunction predicts
dverse outcomes in women with signs and symptoms of ischemia. Coronary microvascular
unction was assessed in women referred for angiography by measuring coronary flow reserve
CFR) after injecting adenosine into the left main artery. The rate of major adverse outcomes
as 27% in those with CFR 2.32, compared with 12% for those with a higher CFR.
mong women with suspected ischemia and atherosclerosis risk factors, measuring CFR may
elp to identify those at highest risk for subsequent events.IPIDS AND RISK2833Genetic Polymorphism Associated With Lower LDL-C, Lower Risk of IHDarianne Benn, Børge G. Nordestgaard, Peer Grande, Peter Schnohr, Anne Tybjærg-Hansen
roprotein convertase subtilisin/kexin type 9 (PCSK9) modulates plasma levels of low-density
ipoprotein cholesterol (LDL-C) by promoting the degradation of low-density lipoprotein
eceptors. Benn and colleagues examined the effect of genetic polymorphisms in PCSK9 on
DL-C levels and the risk of ischemic heart disease (IHD) and mortality in 3 studies with
lmost 45,000 subjects. In carriers of the 46L allele (2.6%), LDL-C levels were 12% lower
nd the risk of IHD was 28% lower. In other lipid intervention trials, a 12% lowering of
DL-C resulted in only a 5% reduction in risk of IHD. The substantial reduction in risk
ith modestly lower LDL-C implies that genotype may be a better measure of life-long
xposure to LDL-C and thus to its negative effects.
ditorial Comment: Christopher Newton-Cheh, J. Gustav Smith, p. 2843(continued on page A-20)
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cIPIDS AND RISK2846Higher Rate of Incident Cancer in Those With Low HDL-Caseeb Jafri, Alawi A. Alsheikh-Ali, Richard H. Karas
afri and colleagues studied the relationship between high-density lipoprotein cholesterol
HDL-C) levels and the risk of cancer using baseline HDL-C levels from several lipid
ntervention trials. Twenty-four eligible trials with over 600,000 person-years of follow-up
nd 8,185 incident cancers were included. There was a significant inverse association between
aseline HDL-C levels and the rate of incident cancer that persisted after adjusting for
everal baseline factors. For every 10-mg/dl increment in HDL-C, there was a 36% lower
ate of developing cancer. These results suggest that low HDL-C is a risk factor for
ncident cancer, possibly because HDL-C has protective anti-inflammatory properties.ditorial Comment: Jennifer G. Robinson, p. 2855OSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME
2858ostural Orthostatic Tachycardia Syndrome Associated With Small Cardiac
Volumes, Responds to Exercise Trainingi Fu, Tiffany B. VanGundy, M. Melyn Galbreath, Shigeki Shibata, Manish Jain, Jeffrey L. Hastings,
aul S. Bhella, Benjamin D. Levine
atients with postural tachycardia syndrome (POTS) have marked increases in heart rate
uring orthostasis; however, the underlying mechanisms are unknown and the effective
herapy is uncertain. Fu and colleagues compared 27 subjects with POTS to healthy controls;
he subjects were then enrolled in an exercise training class. Left ventricular mass, blood
olume, and stroke volume while standing were smaller in subjects compared with controls;
onversely, upright heart rate and total peripheral resistance were greater. Short-term exercise
raining was well tolerated and increased left ventricular mass and blood volume by 12%
nd 7%, decreased upright heart rate by 9 beats/min, and improved patients’ quality of life.
hese results suggest that the tachycardia is caused by a small heart coupled with reduced
lood volume and that exercise training can improve or even cure this syndrome.PRE-CLINICAL RESEARCH RE-CLINICAL RESEARCH
2869lavanol Found in Cacao Limits Damage
Caused by Coronary Occlusion in Rat Modelatrina Go Yamazaki, Pam R. Taub, Maraliz Barraza-Hidalgo, Maria M. Rivas,
lexander C. Zambon, Guillermo Ceballos, Francisco J. Villarreal
ome of the flavanols found in cacao induce nitric oxide synthesis-dependent vasodilation,
nd they may inhibit platelet aggregation and lipid oxidation; ()-epicatechin is one
f these flavanols. Yamazaki and colleagues compared outcomes in rats pre-treated with
)-epicatechin or placebo who underwent coronary artery ligation. The results showed that
re-treatment with ()-epicatechin reduced infarct size at 48 h by 52%. After 3 weeks, active
reatment resulted in a 33% reduction in infarct size and improved left ventricular pressure-
olume curves. These results suggest a unique capacity of ()-epicatechin to confer sustained
ardioprotection in the setting of a permanently occluded coronary artery.
